Skip to content
Colorectal Cancer Clinical Trials

St Louis, Missouri

Colorectal cancer clinical trials in St Louis, MO

63 colorectal cancer studies are recruiting participants at sites in St Louis as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

St Louis at a glance

  • 63 studies are recruiting at a site in St Louis.
  • By phase: Phase 1 (16), Phase 1/2 (14), Phase 2 (4), Phase 2/3 (2), Phase 3 (7), Phase 4 (1), No phase (8), Observational (11). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (40), university, hospital or other (21), government (2).
  • Most recent update to one of these records: November 12, 2026.

Studies recruiting in St Louis

Basic details from each study's public record (the 30 most recently updated of 63). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Study site
    Washington University Medicine
    Registry record
    NCT06270706 · updated
  2. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Washington University
    Registry record
    NCT07659795 · updated
  3. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Washington University School of Medicine
    Registry record
    NCT07020221 · updated
  4. The Vanguard Study: Testing a New Way to Screen for Cancer

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Washington University School of Medicine
    Registry record
    NCT06995898 · updated
  5. Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Study sites
    Mercy Hospital Saint Louis · Mercy Hospital South · Mercy Infusion Center - Chippewa
    Registry record
    NCT07018869 · updated
  6. Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

    • Observational
    • Ages 60 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Study site
    Missouri Baptist Medical Center
    Registry record
    NCT03998202 · updated
  7. FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Oncolytics Biotech
    Study site
    Washington University School of Medicine
    Registry record
    NCT07446322 · updated
  8. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    Mercy Hospital Saint Louis · Mercy Hospital South · Mercy Infusion Center - Chippewa
    Registry record
    NCT05080673 · updated
  9. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    Mercy Hospital Saint Louis · Mercy Hospital South · Mercy Infusion Center - Chippewa
    Registry record
    NCT05174169 · updated
  10. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    Mercy Hospital Saint Louis · Mercy Hospital South · Mercy Infusion Center - Chippewa
    Registry record
    NCT05334069 · updated
  11. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Study sites
    Mercy Hospital Saint Louis · Mercy Hospital South · Missouri Baptist Medical Center
    Registry record
    NCT06418204 · updated
  12. A Study of LY4257496 in Participants With Cancer (OMNIRAY)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Washington University
    Registry record
    NCT07114601 · updated
  13. A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Washington University School of Medicine in St. Louis
    Registry record
    NCT07213791 · updated
  14. Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    Mercy Hospital Saint Louis · Mercy Hospital South · Mercy Infusion Center - Chippewa
    Registry record
    NCT07283939 · updated
  15. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Siteman Cancer Center
    Registry record
    NCT07397338 · updated
  16. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    Mercy Hospital Saint Louis · Mercy Hospital South · Missouri Baptist Medical Center
    Registry record
    NCT05673148 · updated
  17. Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Sairopa B.V.
    Study site
    Washington University Medical Campus
    Registry record
    NCT05856981 · updated
  18. A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Washington University School Of Medicine
    Registry record
    NCT06662786 · updated
  19. A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Washington University School Of Medicine
    Registry record
    NCT06750094 · updated
  20. Family Communications After Genetic Testing

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    Mercy Hospital Saint Louis · Mercy Hospital South · Mercy Infusion Center - Chippewa
    Registry record
    NCT07143487 · updated
  21. A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Washington University School of Medicine in St. Louis
    Registry record
    NCT07416552 · updated
  22. Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Study site
    Washington University Saint Louis
    Registry record
    NCT07702032 · updated
  23. A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Study site
    Washington University School of Medicine at St Louis
    Registry record
    NCT03526835 · updated
  24. A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Incyte Corporation
    Study site
    Washington University School of Medicine
    Registry record
    NCT07284849 · updated
  25. A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Inc
    Study site
    Washington University School of Medicine
    Registry record
    NCT07094204 · updated
  26. Lead-212 PSV359 Therapy for Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 to 90
    • All sexes
    Sponsor
    Perspective Therapeutics
    Study site
    Saint Louis University
    Registry record
    NCT06710756 · updated
  27. Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    A2 Biotherapeutics Inc.
    Study site
    Washington University
    Registry record
    NCT04981119 · updated
  28. A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Alterome Therapeutics, Inc.
    Registry record
    NCT06835569 · updated
  29. JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Jacobio Pharmaceuticals Co., Ltd.
    Study site
    Washington University
    Registry record
    NCT06973564 · updated
  30. A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Washington University School OF Medicine-Siteman Cancer Center
    Registry record
    NCT07221357 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in St Louis, MO on ClinicalTrials.gov.

Ask about studies near St Louis

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call